Icknield is pleased to see that former client Allergy Therapeutics plc has completed a £20m equity fund raising to progress it’s US clinical development programme.
Steve Smith continues to be a non-executive director of Allergy Therapeutics.
Icknield’s former client raises £20m equity funds
Leave a Reply
